Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Diagnosis by John Thomas Cunningham, Iv
Introduction
John Thomas Cunningham, Iv is an accomplished inventor based in Maineville, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of cancer research. His innovative work focuses on developing methods for diagnosing clear cell renal cell carcinoma, a type of kidney cancer.
Latest Patents
Cunningham holds a patent for diagnostic tools and treatments for clear cell renal cell carcinoma. The patent describes a method for diagnosing the likelihood of recurrence of this cancer by detecting gene expression signatures in kidney tumor tissue samples. Specifically, the method involves identifying the expression of mitochondrial electron transport chain subunits, mitochondrial ribosomal proteins, and major histocompatibility complex class II (MHC-II) proteins. If certain gene expression signatures are present, it indicates an elevated risk of recurrence. Additionally, the method incorporates the use of copper levels to further assess the likelihood of recurrence.
Career Highlights
Cunningham is affiliated with the University of Cincinnati, where he continues to advance his research in cancer diagnostics. His work has the potential to significantly impact patient outcomes by providing more accurate assessments of cancer recurrence risks.
Collaborations
Cunningham collaborates with notable colleagues such as Maria Franciszka Czyzyk-Krzeska and Julio Alberto Landero Figueroa. Their combined expertise enhances the research efforts in the field of cancer diagnostics.
Conclusion
John Thomas Cunningham, Iv's innovative approach to diagnosing clear cell renal cell carcinoma exemplifies the critical role of inventors in advancing medical science. His contributions are paving the way for improved diagnostic methods that can ultimately save lives.